4.2 Editorial Material

Are we prepared for change? The need for evidence on healthcare practitioner readiness for current and future trends in abortion provision in the UK

Related references

Note: Only part of the references are listed.
Article Family Studies

Abortion regulation in Europe in the era of COVID-19: a spectrum of policy responses

Caroline Moreau et al.

Summary: The COVID-19 pandemic has impacted abortion care in Europe, with some countries banning or suspending services and others implementing changes to ensure access. Lack of unified policy response has widened inequities, but innovations like telemedicine during the outbreak have the potential to improve continuity and equity of abortion care.

BMJ SEXUAL & REPRODUCTIVE HEALTH (2021)

Article Obstetrics & Gynecology

Client satisfaction and experience of telemedicine and home use of mifepristone and misoprostol for abortion up to 10 weeks' gestation at British Pregnancy Advisory Service: A cross-sectional evaluation

Marielle E. Meurice et al.

Summary: The study found high satisfaction with telemedicine consultation and home use of mifepristone and misoprostol for abortion. Factors associated with health care provider contact included dissatisfaction with pain control and waiting more than one week to use mifepristone.

CONTRACEPTION (2021)

Review Medicine, General & Internal

Self-administered versus provider-administered medical abortion

Katherine Gambir et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2020)

Article Family Studies

Vacuum aspiration for induced abortion could be safely and legally performed by nurses and midwives

Sally Sheldon et al.

JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE (2017)